Dr. James Drake, Inventor of Medafor's MPH™ Technology, Named "Innovator of the Year"
Minneapolis, Minn., August 20, 2003 - Medafor, Inc., announced today that Dr. James Drake, Medafor's Chief Scientist and the inventor and patent holder of Medafor's MPH (Microporous Polysaccharide Hemospheres) hemostatic technology, has been named an Innovator of the Year by Finance and Commerce Daily Business Newspaper, a publication of Dolan Media, Minneapolis. READ FULL STORY.

Medafor, Inc., Relocates to Larger Facility in Brooklyn Center, Minnesota
Minneapolis, Minn., July 10, 2003 -- Medafor, Inc., announced today that it has relocated its corporate headquarters to Brooklyn Center, a northern suburb of Minneapolis. The move accomplished a number of enhancements to the company's operations and customer service capabilities. READ FULL STORY.

SIR 2003
Medafor will introduce its innovative MPatcH hemostatic bandage at the Society of Interventional Radiology in Salt Lake City this month. The MPatcH is designed to provide virtually instant hemostasis and closure at vascular access sites subsequent to diagnostic and interventional procedures. The MPatcH and its patented component MPH hemostatic agent will be demonstrated each day, throughout the duration of the conference, at the Medafor booth, number 1409.